Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P83
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202526.41%
2024-1671.49%
2023105.85%
2022-142.70%
2021-103.95%
2020-244.79%
20190.00%